News

Stay up to date with the latest COVID-19 news from Contagion.

Jason Pogue, PharmD, BCPS, BCIDP, shares his thoughts on a study published in the International Journal of Antimicrobial Agents.

Contagion is partnering with PER to host a live CME-Certified webinar on what clinicians need to know about COVID-19.

The impact of COVID-19 on cardiovascular health is an urgent question for clinicians around the world during this global pandemic.

A study has examined the availability of negative vaccine information online.

A Central Science report from the CAS division of the American Chemical Society details developments and recommends directions against COVID-19 pandemic.

The vast majority of patients with a documented penicillin allergy are not actually at risk from the antibiotic. New research aims to help remove the “allergic” label from some patients’ records.

Countries around the world have struggled to keep the spread of COVID-19 in check. In countries with relatively few resources and weak public health infrastructure, the challenge is even more acute.

A quick and effective response by health officials in Uganda stopped a case of imported pneumonic plague from spreading, according to a recent Morbidity and Mortality Weekly Report.

What does it look like when a health system switches from 'containment' to 'mitigation'?

Older people in low-income countries are especially at risk for COVID-19.

The European Union is rethinking its approach to border crossings as the region deals with the COVID-19 pandemic.

FDA grants emergency use authorization for Cepheid's point-of-care COVID-19 diagnostic, Xpert Xpress SARS-CoV-2.

Lopinavir-ritonavir worked against SARS, but it had little effect against coronavirus compared to standard care.

Here is a look at infectious disease-related FDA news from the week of March 15, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay on top of coronavirus developments from March 20, 2020.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

New analyses of the novel coronavirus and previously circulating SARS viruses reveal promising immunologic targets for vaccine against COVID-19.

Several states are escalating their COVID-19 response measures.

Events that host at-risk people should consider canceling, postponing, or limiting in-person attendance.

The FDA has issued Emergency Use Authorization for another COVID-19 test, produced by Genmark Diagnostics.

A new paper describes how one Singaporean hospital responded to the 2003 severe acute respiratory syndrome (SARS) outbreak, and how those lessons can inform the response to the current pandemic.

The agency notes that they are working closely with industry officials to expedite efforts to develop countermeasures for COVID-19.

Stay on top of coronavirus developments from March 19, 2020.

George Hanna, MD, vice president and therapeutic head of infectious diseases at Merck Laboratories, discusses data from CROI 2020 on islatravir.

The FDA approved a combination therapy of sofosbuvir and velpatasvir to treat children with hepatitis C virus.

The US government has ambitious goals to expand the number of people tested and treated for HIV in the coming years. A new study details the best interventions to make the biggest difference for the most people.

The FLU-v experimental vaccine designed to protect across influenza strains showed promising results in a recent clinical trial.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.